title: Brexpiprazole, cariprazine hydrochloride, and flibanserin.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Rebecca
authors.initials: R
authors.lastname: Shatynski
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001562:Benzimidazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D010879:Piperazines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy; D013876:Thiophenes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D001562:Benzimidazoles; D010879:Piperazines; D015363:Quinolones; D013876:Thiophenes; C000591922:brexpiprazole; C098107:flibanserin; C533287:cariprazine